RenovoRx, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
RenovoRx, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q3 2024.
  • RenovoRx, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $357K, a 77.1% decline year-over-year.
  • RenovoRx, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $952K, a 63.8% decline year-over-year.
  • RenovoRx, Inc. annual Nonoperating Income (Expense) for 2023 was $1.16M, a 1808% increase from 2022.
  • RenovoRx, Inc. annual Nonoperating Income (Expense) for 2022 was $61K.
  • RenovoRx, Inc. annual Nonoperating Income (Expense) for 2021 was -$653K, a 9.93% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $952K $357K -$1.21M -77.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $2.16M $645K -$403K -38.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.56M $1.4M +$1.4M +34900% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.16M -$1.45M -$1.46M -10457% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $2.63M $1.56M +$1.54M +6148% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.09M $1.05M +$1.03M +5140% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $63K $4K +$2K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $61K $14K +$12K +600% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $49K $25K +$141K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$92K $20K +$464K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-16
Q1 2022 -$556K $2K +$97K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$653K $2K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$116K +$70K +37.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$444K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$95K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$186K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.